Ph.D Andrei RĂDULESCU

tranzactiibursiere.ro
  • No tags were found...

ATB 15.03.2013.pdf - Portal SSIF Broker

• With almost 6 decades of tradition in the Romanian pharma

sector, ATB manufactures over 150 medicines, used for the

treatment of several diseases (infectious, dermatology,

cardiovascular, digestive and musculoskeletal);

• At the same time, ATB is an important producer of Nystatin,

with a global market share of 35%;

• Listed on Bucharest Stock Exchange since 1997, the main

shareholder is the Romanian Government (53%);

• The turnover rose at CAGR 10% during the period 2003-

2012, to RON 297mn;

• Over the past years ATB focused on the internationalisation:

the volume of exports rose from USD 13.2mn in 2009 to USD

20mn in 2012 and the management expects an increase to

USD 23.5mn in 2013.

2

More magazines by this user
Similar magazines